Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

Isotechnika Pharma Inc > YA! WHY ? For "ignore'amusi" whose ignore.........
View:
Post by ISAloser247 on Dec 10, 2012 9:57am

YA! WHY ? For "ignore'amusi" whose ignore.........

function is always on,  YOU sure seem to respond to my posts quite often!   SIDE EFFECTS from the psoriasis meds, treating YOU for DEMENTIA, like throughmud, macbethorfaust, isatheone???  don't take too much,  YOU'LL  end up like snrkid !.....  pumper heaven.after scamming for years!
Comment by klank37 on Dec 11, 2012 10:48am
Well here it is ISAloser247. You are right I have and ignore on you but still check on your post. I guess I have been guilty of being on your case...but you should be allowed of your own opinion + I don't have to look at your post but I do. I'm the one guilty. I apologized to you. SINCERELY. Klank p.s I know this company as done weird stuff.....but they are still going to my point of view ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities